These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 5646850)

  • 21. Walker carcinosarcoma 256 in study of anticancer agents. I. Method for simultaneous assessment of therapeutic value and toxicity.
    Rosenoer VM; Mitchley BC; Roe FJ; Connors TA
    Cancer Res; 1966 Aug; 26(8 Pt 2):937-41. PubMed ID: 5212554
    [No Abstract]   [Full Text] [Related]  

  • 22. The effect of in situ isolated perfusion of experimental renal tumors with cytotoxic agents in high concentration.
    Asbach HW; Bersch W
    Urol Int; 1980; 35(2):112-24. PubMed ID: 7376296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of melatonin treatment on growth of Walker carcinosarcoma in rats].
    Bostelmann W; Göcke H; Ernst B; Tessmann D
    Zentralbl Allg Pathol; 1971; 114(3):289-91. PubMed ID: 4326959
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effects of cyclophosphamide and 2,3,5-tris-ethyleniminobenzoquinone-(1,4) on tumor cells in diffusion chambers].
    Teichmann B
    Arzneimittelforschung; 1965 May; 15(5):532-4. PubMed ID: 5898339
    [No Abstract]   [Full Text] [Related]  

  • 25. [Therapeutic experiments with spores of strain Clostridium butyricum and Cyclophosphamide in Jensen sarcoma, Walker carcinoma, and DS carcinosarcoma of the rat (author's transl)].
    Kretschmer H; Ludewig R; Hambsch K
    Arch Geschwulstforsch; 1974; 44(1):65-9. PubMed ID: 4447441
    [No Abstract]   [Full Text] [Related]  

  • 26. Development of experimental models for meningeal neoplasia using intrathecal injection of 9L gliosarcoma and Walker 256 carcinosarcoma in the rat.
    Kooistra KL; Rodriguez M; Powis G; Yaksh TL; Harty GJ; Hilton JF; Laws ER
    Cancer Res; 1986 Jan; 46(1):317-23. PubMed ID: 3753551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Topical chemotherapy of intradermal Walker 256 carcinosarcoma with diaziquone and doxorubicin in the rat.
    Moore DJ; Powis G; Richardson RL; Pittelkow MR
    Cancer Res; 1985 Nov; 45(11 Pt 1):5466-72. PubMed ID: 4053022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of N-acetylcysteine on the antitumor activity of cyclophosphamide against Walker-256 carcinosarcoma in rats.
    Harrison EF; Fuquay ME; Hunter HL
    Semin Oncol; 1983 Mar; 10(1 Suppl 1):25-8. PubMed ID: 6836324
    [No Abstract]   [Full Text] [Related]  

  • 29. Therapy of solid Walker carcinosarcoma 256 with bleomycin after synchronization with hydroxyurea.
    Volm M; Mattern J; Weber N; Wayss K
    Cancer Chemother Pharmacol; 1980; 4(2):89-93. PubMed ID: 6156026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Enhancement of the antitumor effect of cyclophosphane in an experiment].
    Chissov VI; Rusakov IG; Shchitkov KG; Igitov VI; Solodovnik VD
    Vopr Onkol; 1985; 31(12):80-6. PubMed ID: 4082511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on the effect of tumor type and route of administration on the antitumor activity of the amino acid mimosine (NSC-69188).
    DeWys WD; Hall TC
    Cancer Chemother Rep; 1973 Feb; 57(1):41-9. PubMed ID: 4704102
    [No Abstract]   [Full Text] [Related]  

  • 32. [Ineffectiveness of a drug combination on Yoshida sarcoma and Walker carcinosarcoma 256 of the rat and on Ehrlich carcinoma of the mouse].
    Zeller WJ; Wiessler M; Adzersen KH
    Arzneimittelforschung; 1972 Mar; 22(3):575-7. PubMed ID: 5067931
    [No Abstract]   [Full Text] [Related]  

  • 33. [Experimental data to substantiate the antitumor action of hydrazine sulfate].
    Tret'iakov AV; Filov VA; Riazanov EM; Tarkov AS
    Vopr Onkol; 1979; 25(6):100-3. PubMed ID: 462860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Characteristics of growth and sensitivity to cytostatics of Walker 256 carcinosarcoma in randombred and Wistar rats].
    Karaivanova MK
    Eksp Med Morfol; 1974; 13(4):237-42. PubMed ID: 4219353
    [No Abstract]   [Full Text] [Related]  

  • 35. Naringin inhibits tumor growth and reduces interleukin-6 and tumor necrosis factor α levels in rats with Walker 256 carcinosarcoma.
    Camargo CA; Gomes-Marcondes MC; Wutzki NC; Aoyama H
    Anticancer Res; 2012 Jan; 32(1):129-33. PubMed ID: 22213297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Kinetics of the change in free radical content during the development of Walker carcinosarcoma and the action of Thio-TEPA].
    Saprin AN; Minenkova EA; Nagler LG; Kaznacheev IuS; Krugliak SA; Krugliakova KE; Emanuél' NM
    Biofizika; 1967; 12(6):1099-103. PubMed ID: 4318224
    [No Abstract]   [Full Text] [Related]  

  • 37. New nitrosamines.
    Bahner CT; Brotherton D; Brotherton MK
    J Med Chem; 1968 Mar; 11(2):401-2. PubMed ID: 5663646
    [No Abstract]   [Full Text] [Related]  

  • 38. [No effect of partial hepatectomy on the survival time of rats with Walker carcinosarcoma].
    Volm M; Wayss K
    Z Naturforsch B; 1971 Nov; 266(11):1199-200. PubMed ID: 4400304
    [No Abstract]   [Full Text] [Related]  

  • 39. [Comparative study of cyclophosphamide, ifosfamide and trofosfamide on Walker-256 carcinosarcoma in embryonated chicken eggs].
    Norpoth K; Witting U; Rauen HM
    Arzneimittelforschung; 1974 Jan; 24(1):86-9. PubMed ID: 4406116
    [No Abstract]   [Full Text] [Related]  

  • 40. [Disorders of blood rheology in Walker's carcinosarcoma-256 and in cyclophosphamide treatment of rats].
    Plotnikov MB; Maslov MIu; Aliev OI; Vasil'ev AS; Zueva EP; Krylova SG; Shilova NV
    Vopr Onkol; 2001; 47(3):335-7. PubMed ID: 11544834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.